As of Q1'26 (2025-12-28), SBUX reported SG&A Expenses of $639M USD, while R&D Expenses remained at $0 USD. This latest data point continues the trend of zero R&D spending and highlights that SG&A remains the sole component of operating expenses for the company. Over the period from Q2'23 to Q1'26, SG&A Expenses for SBUX have fluctuated within a relatively narrow range, generally between $576M and $678M USD per quarter, without a clear upward or downward trend. The absence of R&D Expenses throughout the entire timeframe indicates a consistent allocation strategy, with operating expenses dominated by SG&A activities and no investment in research and development.